Introduction
Patients with a chronic disease may need support to manage everyday activities and thus maintain a meaningful life.
1 Systematic reviews of chronic disease recommend different forms of exercise, to reach a higher functional level. [2] [3] [4] [5] However, motivational and psychological factors can influence whether a person continues to be active and how he/she self-manages this activity. 6 Therefore, providing continuous support in the chronic stage of diseases may prove beneficial. Denmark is a welfare state with a population of 5.7 million and a publicly funded health care system. This healthcare system includes the right to free of charge physiotherapy (FCP) for patients with severe physical disability or progressive disease who fulfill strict diagnostic criteria specified by the Ministry of Health. FCP is provided by private primary care clinics on a contract with the Ministry of Health. Every 4 weeks, the primary care clinics get reimbursements through the tax-financed health care system. In 2016 the FCP service included more than 67,000 patients and the economic burden was more than 850 million Danish Kroner/113 million Euro (National Health Service Registry).
The purpose of FCP is either to increase or maintain function, or to delay loss of function by providing treatment and team-based training. Patients are referred to FCP by primary care or hospital-based medical specialist. The specific criteria for receiving FCP include (i) having one of 43 FCP diagnoses defined The Danish Health Authority, 7 (ii) having a severe physical disability, defined as "a person who cannot manage her-or himself indoors for 24 hrs without help or aids for daily personal living", and iii) having a prognosis that the disease will last more than 5 years. In August 2008, FCP was expanded to include patients with a progressive disease, defined as "an abnormal function of the sensor-motoric system or nervous system", and patients in this group no longer needed a severe physical disability to be eligible to receive FCP. The four largest disease groups receiving FCP are stroke, multiple sclerosis (MS), Parkinson's disease (PD) and rheumatoid arthritis (RA). These groups account for more than half of the FCP population. Until now, nothing has been published on demographics or incidence of referral in patients receiving FCP in Denmark.
Increasing elder population and the expectations of a higher incidence of chronic disease in the future motivate more knowledge on services such as FCP. The aim of this study is to investigate the incidence of referral to FCP in stroke, PD, MS and RA patients in the period from 2007 to 2016.
Materials and Methods

Data Sources
We conducted a population-based, nationwide cohort study. All data were retrieved from Danish administrative registries through Statistics Denmark. 8 The Danish National Patient Registry (DNPR) contains data on all hospital contacts, including ambulatory visits, and serves as a registry for hospital payments and thus considered largely complete. 9 The National Health Service Registry (DHSR) 10 contains data on primary health care services, including amount and type of FCP, and coverage is assumed to be good as it serves as a registry for reimbursements. Data were linked across registries using the personal identification number assigned to all citizens in Denmark. 
Study Population
We obtained data from the DNPR on all residents in Denmark registered with a primary ICD10 diagnosis of stroke (DI60.0-DI60.9, DI61-DI64, DG45.0-DG45.2, DG45.8, DG45.9), PD (DG20, DG21.0-DG21.3, DG21.8-DG21.9, DG22), MS (DG35) or RA (DM05.0, DM05.9, DM06.0, DM06.9, DM12.3) from 1998 to 2016 (n=311,491). The validity of stroke, PD, MS and RA diagnoses in the DNPR has previously been reported. [12] [13] [14] [15] Patients were divided into four groups, each of them including patients diagnosed with only the specific disease of interest (Stroke, PD, MS, RA) and a fifth mixed group including the patients registered with two or more of the four diseases of interest.
Based on these data, we identified patients over a 10 
Data Analysis
Data on FCP services were retrieved for all participants from the DHSR. As the FCP services are reimbursed every 4 weeks, we defined FCP after the diagnosis as FCP reimbursements >4 weeks after the date of the hospital diagnosis. FCP before the diagnosis was defined as FCP reimbursements before or up to 4 weeks after the hospital diagnosis. The proportion of individuals with FCP was calculated as the cumulated incidence proportion (CIP). Individuals were followed until the first session of FCP after the hospital diagnosis, death (competing event), or the end of follow-up (December 2016), whichever occurred first.
At time points 0.5, 1, 2, 3, 4, and 5 years the overall CIP and the CIP among those not receiving FCP before the hospital diagnosis was calculated for each of the four diagnoses. As the level of dependence and thereby the need for FCP may differ within the stroke sub-diagnoses, the CIP was additionally graphed for each sub-diagnosis of stroke.
To explore time trends in the use of FCP, the CIP was graphed separately for each calendar year of diagnosis grouped in 2-year periods. To explore whether the legislative changes in 2008 affected the access to FCP, the CIP was also graphed separately for the year 2007.
All analyses were performed using STATA version 15 (StataCorp LP, College Station, Texas)
Results
Our study included 174,714 individuals. Of these, 83% had a stroke diagnosis, 4% had a PD diagnosis, 3% had an MS diagnosis, and 9% had an RA diagnosis. One hundred twenty-seven thousand five hundred and thirtyone (73%) of these individuals were followed until their last FCP session or the end of the study period, and 47,183 (27%) died. The percentage of deceased patients within the individual diagnoses was 30% among stroke patients, 21% among PD patients, 2% among MS patients, and 10% among RA patients. FCP was provided for 26,152 individuals with stroke (56%), PD (16%), MS (14%) and RA (14%). The percentage of patients receiving FCP before the hospital diagnosis increased over the study period. Further characteristics of the individuals receiving FCP are presented in Table 1 .
The Incidence of Referral to FCP After the First Hospital Diagnosis
Patients with PD and MS were the quickest to begin FCP with 20% of PD patients and 13% of MS patients starting FCP within 2 months of their diagnosis. FCP was mainly initiated within 2 years of the first hospital diagnosis. The overall CIP of FCP 2 years after the first hospital diagnosis was 8% (95% Confidence Interval (CI), 8-9%)) for stroke, 53% (95% CI; 52-54%) for PD, 49% (95% CI, 48-51%) for MS, and 16% (95% CI, 16-17%) for RA ( Table 2) . The CIP among patients not receiving FCP before the hospital diagnosis was lower (Table S1 ).
Patients with mild Stroke (transischemic attack and arterial syndrome) had the lowest CIP within subdiagnoses of stroke ( Figure S1 ).
The overall CIP from 2011 to 2016 was similar or higher compared with the CIP from 2007 to 2010 (eg, the two-year CIP for patients diagnosed with PD from 2007 to 2008 and from 2015 to 2016 was 45% and 58%, respectively (Figure 1) ). Looking only at patients not receiving FCP before the hospital diagnosis, only PD patients had higher CIP in the later period compared with the earlier period ( Figure 1B) .
The CIP among RA patients diagnosed between 2015 and 2016 was lower compared with previous years ( Figure 1A and B). The CIP among those diagnosed with RA or PD in 2007 was lower compared with later years ( Figure S2 ).
Discussion
Using population-based, nationwide registers, we found that FCP was mainly initiated within the first 2 years after the first hospital diagnosis of stroke, PD, MS or RA. The two-year proportion of FCP was highest in PD (53%) and MS (49%) patients and lowest in RA (16%) and stroke (8%) patients. The proportion of patients referred to FCP generally increased over the period of study, especially in patients with PD and MS.
To our knowledge, this is the first study to report on the incidence of FCP in chronic disease. The study has some limitations. Firstly, we excluded patients with two or more diseases. As these patients presumably had lower functional ability due to multi-morbidity, this exclusion may have resulted in an underestimation of the number of patients being referred for FCP. Secondly, some patients may have received municipal physiotherapy under the law of social services. As patients are not allowed to receive both FCP and municipal physiotherapy, we ideally should have included these patients as having competing events to reduce the potential underestimation of FCP. However, data on municipal physiotherapy have not been systematically recorded in the 98 municipalities in Denmark.
Third, we were unable to identify and include patients not registered in the DNPR. These patients, if any, would likely have a higher functional ability (as they were not hospitalized) and thus not require FCP. Excluding these patients may have resulted in an overestimation of the number of patients being referred for FCP. Another potential overestimation could have occurred if patients were diagnosed in the hospital before 1998 and not hospitalized in the subsequent period between 1998 and 2007 (the period used to define incident patients from 2007). However, hospitalization is likely in stroke, PD, MS and RA patients, and therefore the risk of overestimating the number of patients with FCP after incident hospital diagnosis is minimal. Finally, it should be noted that the year of incident hospital diagnosis may not reflect the true year of diagnosis, as some patients may have first been diagnosed outside the hospital, eg, by a primary care medical specialist. This applies particularly to patients with PD and MS, which may explain our finding that these patients were the quickest to begin FCP. Overall it makes good sense that FCP was mainly initiated within the first 2 years of diagnosis. A reason for late initiation could be increased disability over time. A possible explanation for the low proportion of stroke patients referred to FCP is that the majority of patients had little or no functional disability following their stroke and thus did not require FCP. This was illustrated in patients with mild stroke (eg, transient ischemic attack) who had the lowest incidence of FCP indicating that FCP is related to disease severity. Another reason could be successful acute treatment (thrombolysis). 16 municipality-based rehabilitation for the first year afterwards. 17 The findings that stroke patients had fewer and slower referrals to FCP compared to the other groups and high mortality rate raise the question of whether a more active approach in stroke patients could help to reduce the mortality in this population. 18, 19 The proportion of RA patients referred to FCP was only slightly higher than stroke patients and substantially lower than PD and MS patients. This is surprising, since RA, unlike a stroke but like PD and MS, is a progressive disease. However, patients with RA are being increasingly well treated with medication. 20 Therefore, RA patients decreased the incidence of FCP in the latest study period may indicate a reduced need for physiotherapy.
In patients with PD and MS, the proportion of patients receiving FCP increased over the period of study. This increase could partly be due to the growing amount of evidence over recent years showing the positive effects of training in PD and MS patients. 21, 22 Another reason for the increased incidence of FCP over the study period may be the change in legislation in August 2008, which enabled less severe disabled patients to be referred to FCP. The very low CIP in patients diagnosed with PD in 2007 indicates the immediate effect of the legislative changes in this patient group ( Figure S2 ). The finding of similar rates of FCP over the study period among the MS patients not receiving FCP before the hospital diagnosis ( Figure 1B) indicates that the rise of FCP in this patient group was mostly due to more patients being diagnosed and referred from primary care.
The current study included patients with diagnoses registered by hospital medical specialists in the DNPR. However, patients may be referred to FCP by a primary care medical specialist due to other diagnoses. Therefore, the hospital diagnoses in the DNPR do not necessarily correspond to the FCP referral diagnoses, registered in the DHSR. Future studies should investigate the agreement between the diagnoses from the DNPR and the diagnoses for which the patients receive FCP.
The finding of the very low incidence of FCP in patients with mild stroke indicates that FCP is related to disease severity. Future studies should retrieve data on the degree of severity or dependence from the clinical quality databases for stroke, MS and RA, to explore the incidence of referral within different degrees of dependence.
Conclusion
In the current cohort, we found that FCP was mainly initiated within the first 2 years after the first hospital diagnosis of stroke, PD, MS or RA. The two-year proportion of FCP was highest in patients with PD and MS and the proportion of patients referred to FCP generally increased over the period of study.
